ID   HOME1_MOUSE             Reviewed;         366 AA.
AC   Q9Z2Y3; Q8K3E1; Q8K4M8; Q9Z0E9; Q9Z216;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2003, sequence version 2.
DT   07-APR-2021, entry version 176.
DE   RecName: Full=Homer protein homolog 1 {ECO:0000305};
DE            Short=Homer-1;
DE   AltName: Full=VASP/Ena-related gene up-regulated during seizure and LTP 1;
DE            Short=Vesl-1 {ECO:0000303|Ref.4};
GN   Name=Homer1 {ECO:0000312|MGI:MGI:1347345}; Synonyms=Vesl1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 5).
RC   STRAIN=C57BL/6J; TISSUE=Forebrain;
RX   PubMed=9808458; DOI=10.1016/s0896-6273(00)80588-7;
RA   Xiao B., Tu J.C., Petralia R.S., Yuan J.P., Doan A., Breder C.D.,
RA   Ruggiero A., Lanahan A.A., Wenthold R.J., Worley P.F.;
RT   "Homer regulates the association of group 1 metabotropic glutamate
RT   receptors with multivalent complexes of homer-related, synaptic proteins.";
RL   Neuron 21:707-716(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=BALB/cJ; TISSUE=Heart;
RX   PubMed=12176012; DOI=10.1016/s0006-291x(02)00899-9;
RA   Saito H., Kimura M., Inanobe A., Ohe T., Kurachi Y.;
RT   "An N-terminal sequence specific for a novel Homer1 isoform controls
RT   trafficking of group I metabotropic glutamate receptor in mammalian
RT   cells.";
RL   Biochem. Biophys. Res. Commun. 296:523-529(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 5).
RC   STRAIN=C57BL/6N; TISSUE=Brain cortex;
RA   Inokuchi K., Hayashi F.;
RT   "Mouse Vesl family of EVH-protein that interacts with group I mGluRs.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   STRAIN=129/SvJ; TISSUE=Hippocampus;
RA   Hayashi F., Hirai K., Inokuchi K.;
RT   "Genomic structure of mouse vesl-1 gene.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   INTERACTION WITH GRM1; GRM5; DYN3 AND ITPR1.
RX   PubMed=9808459; DOI=10.1016/s0896-6273(00)80589-9;
RA   Tu J.C., Xiao B., Yuan J.P., Lanahan A.A., Leoffert K., Li M., Linden D.J.,
RA   Worley P.F.;
RT   "Homer binds a novel proline-rich motif and links group 1 metabotropic
RT   glutamate receptors with IP3 receptors.";
RL   Neuron 21:717-726(1998).
RN   [6]
RP   REVIEW.
RX   PubMed=10851183; DOI=10.1016/s0959-4388(00)00087-8;
RA   Xiao B., Tu J.C., Worley P.F.;
RT   "Homer: a link between neural activity and glutamate receptor function.";
RL   Curr. Opin. Neurobiol. 10:370-374(2000).
RN   [7]
RP   TISSUE SPECIFICITY, AND INTERACTION WITH ITPR1.
RX   PubMed=12379179; DOI=10.1016/s0143416002001549;
RA   Salanova M., Priori G., Barone V., Intravaia E., Flucher B., Ciruela F.,
RA   McIlhinney R.A.J., Parys J.B., Mikoshiba K., Sorrentino V.;
RT   "Homer proteins and InsP(3) receptors co-localise in the longitudinal
RT   sarcoplasmic reticulum of skeletal muscle fibres.";
RL   Cell Calcium 32:193-200(2002).
RN   [8]
RP   INTERACTION WITH IFT57.
RX   PubMed=17107665; DOI=10.1016/j.bbrc.2006.10.167;
RA   Sakamoto K., Yoshida S., Ikegami K., Minakami R., Kato A., Udo H.,
RA   Sugiyama H.;
RT   "Homer1c interacts with Hippi and protects striatal neurons from
RT   apoptosis.";
RL   Biochem. Biophys. Res. Commun. 352:1-5(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-318, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [10]
RP   INTERACTION WITH SHANK3.
RX   PubMed=21558424; DOI=10.1093/hmg/ddr212;
RA   Wang X., McCoy P.A., Rodriguiz R.M., Pan Y., Je H.S., Roberts A.C.,
RA   Kim C.J., Berrios J., Colvin J.S., Bousquet-Moore D., Lorenzo I., Wu G.,
RA   Weinberg R.J., Ehlers M.D., Philpot B.D., Beaudet A.L., Wetsel W.C.,
RA   Jiang Y.H.;
RT   "Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms
RT   of Shank3.";
RL   Hum. Mol. Genet. 20:3093-3108(2011).
RN   [11]
RP   TISSUE SPECIFICITY, INTERACTION WITH SHANK3, AND SUBCELLULAR LOCATION.
RX   PubMed=24153177; DOI=10.1038/nature12630;
RA   Han K., Holder J.L. Jr., Schaaf C.P., Lu H., Chen H., Kang H., Tang J.,
RA   Wu Z., Hao S., Cheung S.W., Yu P., Sun H., Breman A.M., Patel A., Lu H.C.,
RA   Zoghbi H.Y.;
RT   "SHANK3 overexpression causes manic-like behaviour with unique
RT   pharmacogenetic properties.";
RL   Nature 503:72-77(2013).
CC   -!- FUNCTION: Postsynaptic density scaffolding protein. Binds and cross-
CC       links cytoplasmic regions of GRM1, GRM5, ITPR1, DNM3, RYR1, RYR2,
CC       SHANK1 and SHANK3. By physically linking GRM1 and GRM5 with ER-
CC       associated ITPR1 receptors, it aids the coupling of surface receptors
CC       to intracellular calcium release. May also couple GRM1 to PI3 kinase
CC       through its interaction with AGAP2. Isoform 1 regulates the trafficking
CC       and surface expression of GRM5. Differentially regulates the functions
CC       of the calcium activated channel ryanodine receptors RYR1 and RYR2.
CC       Isoform 1 decreases the activity of RYR2, and increases the activity of
CC       RYR1, whereas isoform 5 counteracts the effects by competing for
CC       binding sites. Isoform 3 regulates the trafficking and surface
CC       expression of GRM5. Isoform 5 acts as a natural dominant negative, in
CC       dynamic competition with constitutively expressed isoform 1, isoform 2
CC       and isoform 3 to regulate synaptic metabotropic glutamate function.
CC       Isoform 5, may be involved in the structural changes that occur at
CC       synapses during long-lasting neuronal plasticity and development (By
CC       similarity). Forms a high-order complex with SHANK1, which in turn is
CC       necessary for the structural and functional integrity of dendritic
CC       spines (By similarity). Negatively regulates T cell activation by
CC       inhibiting the calcineurin-NFAT pathway. Acts by competing with
CC       calcineurin/PPP3CA for NFAT protein binding, hence preventing NFAT
CC       activation by PPP3CA (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q86YM7, ECO:0000250|UniProtKB:Q9Z214}.
CC   -!- SUBUNIT: Tetramer; this tetrameric structure is critical for forming
CC       the high-order complex with SHANK1, which in turn is necessary for the
CC       structural and functional integrity of dendritic spines (By
CC       similarity). Isoform 1, isoform 2 and isoform 3 encode a coiled-coil
CC       structure that mediates homo- and heteromultimerization. Interacts with
CC       GRM1, GRM5, ITPR1, DNM3, RYR1, RYR2 and SHANK3. Interacts with IFT57
CC       and OPHN1. Interacts with SHANK1; forms high-order polymerized complex
CC       with a mesh-like network structure, at least composed of SHANK1, HOMER1
CC       and DLGAP1; the complex formation is SHANK1 multimerization dependent
CC       (By similarity). Interacts with NFATC4 (By similarity). Interacts with
CC       DAGLA (via PPXXF motif); this interaction is required for the cell
CC       membrane localization of DAGLA (By similarity).
CC       {ECO:0000250|UniProtKB:Q86YM7, ECO:0000250|UniProtKB:Q9Z214,
CC       ECO:0000269|PubMed:12379179, ECO:0000269|PubMed:17107665,
CC       ECO:0000269|PubMed:21558424, ECO:0000269|PubMed:24153177,
CC       ECO:0000269|PubMed:9808459}.
CC   -!- INTERACTION:
CC       Q9Z2Y3; Q9D415: Dlgap1; NbExp=4; IntAct=EBI-396980, EBI-400152;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24153177}. Cell
CC       junction, synapse, postsynaptic density {ECO:0000269|PubMed:24153177}.
CC       Cell junction, synapse {ECO:0000269|PubMed:24153177}. Cell projection,
CC       dendritic spine {ECO:0000250|UniProtKB:Q9Z214}. Note=Isoform 1 inhibits
CC       surface expression of GRM5 causing it to be retained in the endoplasmic
CC       reticulum. The N-terminal of isoform 2 may facilitate trafficking of
CC       the complex with GRM5 from the endoplasmic reticulum (ER) to the plasma
CC       membrane (PM).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Vesl-1L;
CC         IsoId=Q9Z2Y3-1; Sequence=Displayed;
CC       Name=2; Synonyms=1d;
CC         IsoId=Q9Z2Y3-2; Sequence=VSP_009060, VSP_009061;
CC       Name=3; Synonyms=1b;
CC         IsoId=Q9Z2Y3-3; Sequence=VSP_009061;
CC       Name=4; Synonyms=Vesl-1M;
CC         IsoId=Q9Z2Y3-4; Sequence=VSP_009063, VSP_009065;
CC       Name=5; Synonyms=Vesl-1S;
CC         IsoId=Q9Z2Y3-5; Sequence=VSP_009062, VSP_009064;
CC   -!- TISSUE SPECIFICITY: Isoform 1, isoform 3 and isoform 5 are expressed in
CC       skeletal muscle at the level of the Z line, in heart, forebrain and
CC       cerebellum. Isoform 2, is a minor isoform and is expressed in cardiac
CC       and skeletal muscle. Isoform 5 is expressed in the postsynaptic region
CC       of neurons. {ECO:0000269|PubMed:12379179, ECO:0000269|PubMed:24153177}.
CC   -!- DOMAIN: The WH1 domain interacts with the PPXXF motif in GRM1, GRM5,
CC       RYR1, RYR2, ITPR1, SHANK 1 and SHANK3. The coiled-Coil domain forms an
CC       antiparallel tetrameric arrangement (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Z214}.
CC   -!- SIMILARITY: Belongs to the Homer family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF093257; AAC71021.1; -; mRNA.
DR   EMBL; AF093258; AAC71022.1; -; mRNA.
DR   EMBL; AY137385; AAM95461.1; -; mRNA.
DR   EMBL; AB019478; BAA34353.1; -; mRNA.
DR   EMBL; AB019479; BAA34354.1; -; mRNA.
DR   EMBL; AB089435; BAC07257.1; -; mRNA.
DR   CCDS; CCDS26687.1; -. [Q9Z2Y3-5]
DR   CCDS; CCDS36745.1; -. [Q9Z2Y3-1]
DR   CCDS; CCDS36746.1; -. [Q9Z2Y3-2]
DR   CCDS; CCDS70484.1; -. [Q9Z2Y3-3]
DR   CCDS; CCDS84048.1; -. [Q9Z2Y3-4]
DR   RefSeq; NP_001271118.1; NM_001284189.2. [Q9Z2Y3-3]
DR   RefSeq; NP_001334527.1; NM_001347598.1. [Q9Z2Y3-4]
DR   RefSeq; NP_036112.1; NM_011982.4. [Q9Z2Y3-5]
DR   RefSeq; NP_671705.2; NM_147176.4. [Q9Z2Y3-1]
DR   RefSeq; NP_687036.1; NM_152134.3. [Q9Z2Y3-2]
DR   BMRB; Q9Z2Y3; -.
DR   SMR; Q9Z2Y3; -.
DR   BioGRID; 205014; 63.
DR   CORUM; Q9Z2Y3; -.
DR   IntAct; Q9Z2Y3; 51.
DR   MINT; Q9Z2Y3; -.
DR   STRING; 10090.ENSMUSP00000078093; -.
DR   TCDB; 8.A.29.1.1; the homer1 (homer1) family of excitation-contraction coupling proteins.
DR   iPTMnet; Q9Z2Y3; -.
DR   PhosphoSitePlus; Q9Z2Y3; -.
DR   SwissPalm; Q9Z2Y3; -.
DR   PaxDb; Q9Z2Y3; -.
DR   PeptideAtlas; Q9Z2Y3; -.
DR   PRIDE; Q9Z2Y3; -.
DR   ProteomicsDB; 273121; -. [Q9Z2Y3-1]
DR   ProteomicsDB; 273122; -. [Q9Z2Y3-2]
DR   ProteomicsDB; 273123; -. [Q9Z2Y3-3]
DR   ProteomicsDB; 273124; -. [Q9Z2Y3-4]
DR   ProteomicsDB; 273125; -. [Q9Z2Y3-5]
DR   ABCD; Q9Z2Y3; 12 sequenced antibodies.
DR   Antibodypedia; 3836; 349 antibodies.
DR   Ensembl; ENSMUST00000060490; ENSMUSP00000050471; ENSMUSG00000007617. [Q9Z2Y3-3]
DR   Ensembl; ENSMUST00000079086; ENSMUSP00000078093; ENSMUSG00000007617. [Q9Z2Y3-2]
DR   Ensembl; ENSMUST00000080127; ENSMUSP00000079026; ENSMUSG00000007617. [Q9Z2Y3-1]
DR   Ensembl; ENSMUST00000102752; ENSMUSP00000099813; ENSMUSG00000007617. [Q9Z2Y3-5]
DR   Ensembl; ENSMUST00000109492; ENSMUSP00000105118; ENSMUSG00000007617. [Q9Z2Y3-4]
DR   GeneID; 26556; -.
DR   KEGG; mmu:26556; -.
DR   UCSC; uc007rlc.3; mouse. [Q9Z2Y3-1]
DR   UCSC; uc007rld.3; mouse. [Q9Z2Y3-3]
DR   UCSC; uc007rle.3; mouse. [Q9Z2Y3-2]
DR   CTD; 9456; -.
DR   MGI; MGI:1347345; Homer1.
DR   eggNOG; ENOG502QR3K; Eukaryota.
DR   GeneTree; ENSGT00940000156354; -.
DR   HOGENOM; CLU_103795_0_0_1; -.
DR   InParanoid; Q9Z2Y3; -.
DR   OMA; QXSAISK; -.
DR   OrthoDB; 1251658at2759; -.
DR   PhylomeDB; Q9Z2Y3; -.
DR   TreeFam; TF325627; -.
DR   Reactome; R-MMU-6794361; Neurexins and neuroligins.
DR   BioGRID-ORCS; 26556; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Homer1; mouse.
DR   PRO; PR:Q9Z2Y3; -.
DR   Proteomes; UP000000589; Chromosome 13.
DR   RNAct; Q9Z2Y3; protein.
DR   Bgee; ENSMUSG00000007617; Expressed in cerebral cortex and 289 other tissues.
DR   Genevisible; Q9Z2Y3; MM.
DR   GO; GO:0045177; C:apical part of cell; IDA:MGI.
DR   GO; GO:0030424; C:axon; IDA:MGI.
DR   GO; GO:0043034; C:costamere; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0030425; C:dendrite; ISO:MGI.
DR   GO; GO:0043198; C:dendritic shaft; ISO:MGI.
DR   GO; GO:0043197; C:dendritic spine; ISO:MGI.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0043005; C:neuron projection; IDA:BHF-UCL.
DR   GO; GO:0044309; C:neuron spine; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0098794; C:postsynapse; IDA:MGI.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; ISO:MGI.
DR   GO; GO:0030018; C:Z disc; IDA:MGI.
DR   GO; GO:0035256; F:G protein-coupled glutamate receptor binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0044325; F:ion channel binding; ISO:MGI.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:MGI.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:MGI.
DR   GO; GO:0099186; F:structural constituent of postsynapse; ISO:MGI.
DR   GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; ISO:MGI.
DR   GO; GO:0048148; P:behavioral response to cocaine; IMP:MGI.
DR   GO; GO:0048875; P:chemical homeostasis within a tissue; IMP:MGI.
DR   GO; GO:0007216; P:G protein-coupled glutamate receptor signaling pathway; ISO:MGI.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; IMP:MGI.
DR   GO; GO:0035418; P:protein localization to synapse; ISO:MGI.
DR   GO; GO:0051262; P:protein tetramerization; ISS:UniProtKB.
DR   GO; GO:0090279; P:regulation of calcium ion import; IMP:BHF-UCL.
DR   GO; GO:2001257; P:regulation of cation channel activity; IMP:BHF-UCL.
DR   GO; GO:1902950; P:regulation of dendritic spine maintenance; ISS:UniProtKB.
DR   GO; GO:0098962; P:regulation of postsynaptic neurotransmitter receptor activity; IDA:SynGO.
DR   GO; GO:2001256; P:regulation of store-operated calcium entry; IMP:BHF-UCL.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; ISS:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; ISO:MGI.
DR   GO; GO:0003009; P:skeletal muscle contraction; IMP:MGI.
DR   GO; GO:0048741; P:skeletal muscle fiber development; IMP:MGI.
DR   CDD; cd01206; EVH1_Homer_Vesl; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR044100; Homer_EVH1.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000697; WH1/EVH1_dom.
DR   Pfam; PF00568; WH1; 1.
DR   SMART; SM00461; WH1; 1.
DR   PROSITE; PS50229; WH1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell junction; Cell projection;
KW   Coiled coil; Cytoplasm; Phosphoprotein; Reference proteome; Synapse.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YM7"
FT   CHAIN           2..366
FT                   /note="Homer protein homolog 1"
FT                   /id="PRO_0000191006"
FT   DOMAIN          1..110
FT                   /note="WH1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00410"
FT   REGION          302..366
FT                   /note="Required for tetramerization"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z214"
FT   COILED          193..364
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylglycine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YM7"
FT   MOD_RES         318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   VAR_SEQ         1..2
FT                   /note="MG -> MLIHHHNRRALCKGSPTT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12176012"
FT                   /id="VSP_009060"
FT   VAR_SEQ         176..187
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12176012,
FT                   ECO:0000303|PubMed:9808458"
FT                   /id="VSP_009061"
FT   VAR_SEQ         176..186
FT                   /note="SAGDRTQALSH -> RYTFNSAIMIK (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9808458, ECO:0000303|Ref.3"
FT                   /id="VSP_009062"
FT   VAR_SEQ         177..203
FT                   /note="AGDRTQALSHASSAISKHWEAELATLK -> SSRWIFFPYCEDSQLSLLESS
FT                   SGLGYF (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_009063"
FT   VAR_SEQ         187..366
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9808458, ECO:0000303|Ref.3"
FT                   /id="VSP_009064"
FT   VAR_SEQ         204..366
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_009065"
FT   CONFLICT        193
FT                   /note="K -> N (in Ref. 3; BAA34354)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        197
FT                   /note="A -> V (in Ref. 3; BAA34354)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        205
FT                   /note="N -> T (in Ref. 3; BAA34354)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   366 AA;  41413 MW;  6A4CBCE5B8A91A3F CRC64;
     MGEQPIFSTR AHVFQIDPNT KKNWVPTSKH AVTVSYFYDS TRNVYRIISL DGSKAIINST
     ITPNMTFTKT SQKFGQWADS RANTVYGLGF SSEHHLSKFA EKFQEFKEAA RLAKEKSQEK
     MELTSTPSQE SAGGDLQSPL TPESINGTDD ERTPDVTQNS EPRAEPTQNA LPFPHSAGDR
     TQALSHASSA ISKHWEAELA TLKGNNAKLT AALLESTANV KQWKQQLAAY QEEAERLHKR
     VTELECVSSQ ANAVHSHKTE LNQTVQELEE TLKVKEEEIE RLKQEIDNAR ELQEQRDSLT
     QKLQEVEIRN KDLEGQLSDL EQRLEKSQNE QEAFRSNLKT LLEILDGKIF ELTELRDNLA
     KLLECS
//
